CASI Pharmaceuticals
CASI
CASI
74 hedge funds and large institutions have $122M invested in CASI Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 6 closing their positions.
Holders
74
Holders Change
+7
Holders Change %
+10.45%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
13
Increased
30
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CCM
1
Consonance Capital Management
New York
|
$22.4M |
| 2 |
WSCM
2
Wellington Shields Capital Management
New York
|
$6.11M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$9.78M |
| 4 |
WSC
4
Wellington Shields & Co
New York
|
$5.35M |
| 5 |
5
BlackRock
New York
|
$11.3M |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$209K |
| 2 |
2
Millennium Management
New York
|
$381K |
| 3 |
IC
3
Ikarian Capital
Dallas,
Texas
|
$3.74M |
| 4 |
4
Goldman Sachs
New York
|
$87K |
| 5 |
5
Russell Investments Group
London,
United Kingdom
|
$268K |
